174 related articles for article (PubMed ID: 37219741)
1. Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer.
Wolff L; Steindl A; Popov P; Dieckmann K; Gatterbauer B; Widhalm G; Berghoff AS; Preusser M; Raderer M; Kiesewetter B
Clin Exp Metastasis; 2023 Jun; 40(3):217-226. PubMed ID: 37219741
[TBL] [Abstract][Full Text] [Related]
2. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.
Kushchayeva YS; Kushchayev SV; Carroll NM; Felger EA; Links TP; Teytelboym OM; Bonichon F; Preul MC; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM
Thyroid; 2014 Oct; 24(10):1488-500. PubMed ID: 24921429
[TBL] [Abstract][Full Text] [Related]
3. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
7. Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up.
de Melo TG; Zantut-Wittmann DE; Ficher E; da Assumpção LV
J Endocrinol Invest; 2014 Dec; 37(12):1195-200. PubMed ID: 25037473
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer in childhood: a retrospective review of childhood course.
O'Gorman CS; Hamilton J; Rachmiel M; Gupta A; Ngan BY; Daneman D
Thyroid; 2010 Apr; 20(4):375-80. PubMed ID: 20373982
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Oncological Outcomes of Papillary Thyroid Cancer and Follicular Thyroid Cancer in Children: A Nationwide Population-Based Study.
van de Berg DJ; Kuijpers AMJ; Engelsman AF; Drukker CA; van Santen HM; Terwisscha van Scheltinga SCEJ; van Trotsenburg ASP; Mooij CF; Vriens MR; Nieveen van Dijkum EJM; Derikx JPM
Front Endocrinol (Lausanne); 2022; 13():899506. PubMed ID: 35600573
[TBL] [Abstract][Full Text] [Related]
11. uPA receptor expression in benign and malignant thyroid tumors.
Kim SJ; Shiba E; Taguchi T; Tsukamoto F; Miyoshi Y; Tanji Y; Takai S; Noguchi S
Anticancer Res; 2002; 22(1A):387-93. PubMed ID: 12017319
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.
Bhargav PR; Mishra A; Agarwal G; Agarwal A; Pradhan PK; Gambhir S; Verma AK; Mishra SK
World J Surg; 2010 Jan; 34(1):40-7. PubMed ID: 20020292
[TBL] [Abstract][Full Text] [Related]
13. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet).
Locati L; Cavalieri S; Dal Maso L; Busco S; Anderson LA; Botta L; Bento MJ; Carulla M; Chirlaque López MD; Fusco M; Guevara M; Innos K; Børge Johannesen T; Micallef R; Minicozzi P; Panato C; Petrova D; Rubio-Casadevall J; Smailyte G; Francesca Vitale M; Trama A;
Oral Oncol; 2020 Sep; 108():104766. PubMed ID: 32454415
[TBL] [Abstract][Full Text] [Related]
14. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.
Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R
Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044
[TBL] [Abstract][Full Text] [Related]
15. Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study.
Masaki C; Sugino K; Tanizawa Y; Nakamura K; Okada Y; Cai Z; Okamoto T
Drugs Real World Outcomes; 2023 Mar; 10(1):145-158. PubMed ID: 36527599
[TBL] [Abstract][Full Text] [Related]
16. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
Fan YL; Li XQ
Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
[TBL] [Abstract][Full Text] [Related]
18. Bone metastases in newly diagnosed patients with thyroid cancer: A large population-based cohort study.
Zhang R; Zhang W; Wu C; Jia Q; Chai J; Meng Z; Zheng W; Tan J
Front Oncol; 2022; 12():955629. PubMed ID: 36033484
[TBL] [Abstract][Full Text] [Related]
19. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
